Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Radiotherapie met of zonder cisplatine bij lokaal recidief endometriumcarcinoom
jul 2024 | Gynaecologische oncologie, Radiotherapie